We are hiring!

We are looking for a project manager research support. Check the vacancies page.

Netherlands Heart Institute

Excellent science for better care
The Netherlands Heart Institute fosters excellent cardiovascular research on national and international level. We conduct basic science as well as clinical research. We aim to promote cooperation between university medical centres in the Netherlands and between scientists and the private sector.

The Netherlands Heart Institute encourages young, talented researchers and coaches them to the top. We are the platform for the next generation of excellent researchers.

1st Translational Research Meeting, 29-30 June 2017
1st Translational Research Meeting, 29-30 June 2017

The Netherlands Heart Institute is a unique cooperation of the cardiology departments of all eight university hospitals in the Netherlands. We cooperate closely with the Netherlands Heart Foundation.

Please contact one of the members of the board if you want to discuss opportunities for cardiovascular science in the Netherlands or abroad: Pieter Doevendans, Dirk Jan Duncker or Jan Weijers.

Recent news

Life Time Achievement Award for Walter Paulus
Walter Paulus, chair of the international scientific advisory board of the Netherlands Heart Institute, has been granted a Life Time Achievement Award by the Heart Failure Association of the ESC.

Website hereditary cardiac disease
As part of the e-DETECT study of Peter van Tintelen and Folkers Asselbergs a new web site was launched to inform patients with hereditary cardiac disease and their family members.

PLN-information day 2017
The PLN foundation organized an outstanding PLN-patient information day at the AMC on Saturday the 4th of November. More than 250 people participated in an extensive and versatile program, including talks from scientific experts as well as elaborate public discussions between patients, doctors and scientists.

Success for RACE III study
The RACE III study showed that patients with AF and HF treated aggressively for AF risk factors in an early staged developed better sinus rhythm and less permanent AF than patients given the conventional treatment.

More news

Tel: +31.30.2333600      E-mail: info@heart-institute.nl      Twitter: @nl_heart      Facebook: @netherlandsheartinstitute